Draft Guidance on Quality Systems Approach to Pharmaceutical cGMP Regulations
The FDA publish a draft guidance intended to help manufacturers that are implementing modern quality systems and risk management approaches to meet the requirements of the agency's cGMP regulations. The guidance proposes a new Six System Inspection Model where by the Quality System provides the foundation for the 5 manufacturing systems that are linked and function within it.